BioNet has a strong track record with development and biomanufacturing, having advanced over three proprietary recombinant pertussis vaccines from early R&D to licensure.

Pertagen®

Recombinant pertussis vaccine

Boostagen®

Tetanus toxoid, reduced diphtheria toxoid, recombinant pertussis vaccine

Note: Not all products listed in this website may be approved and/or marketed in your region/country. Indications may differ geographically. Please check with your local authority/regulator.